PNS vs TENS for Diabetic Neuropathy: How They Differ & Which Lasts
Short answer: transcutaneous electrical nerve stimulation (TENS) is a surface-level, temporary therapy delivered through skin pads, while peripheral nerve stimulation (PNS) - for example the NS100 60-day percutaneous protocol - places a thin lead near a specific peripheral nerve for targeted stimulation and durable relief that can persist after the lead is removed. This guide compares mechanism, placement, treatment duration, insurance, and candidacy so you and your clinician can decide which fits painful diabetic neuropathy.
# PNS vs. TENS for Diabetic Neuropathy: How the Two Differ
If you have been searching for a "device for neuropathy" or comparing the NS100 nerve stimulator to a TENS unit you can buy online, the underlying technologies are not the same. Both use electrical stimulation, but they target different nerves, use very different hardware, and follow different treatment protocols.
This guide explains the clinical differences between **TENS** (transcutaneous electrical nerve stimulation) and **PNS** (peripheral nerve stimulation), so you can have a more productive conversation with your clinician about chronic pain associated with painful diabetic neuropathy (PDN).
What TENS units do
A TENS unit is a small, battery-powered consumer device. Adhesive pads are placed on the skin over the painful area and deliver a low-voltage electrical current through the skin to nearby sensory nerves. TENS is generally available without a prescription and is used at home for short, on-demand sessions.
- **Where stimulation is delivered:** through the skin, to nearby sensory nerves.
- **Hardware:** external pads and a handheld controller, used at home.
- **Duration:** short sessions, used as needed; benefit typically lasts only while the device is on.
- **Clinical role:** symptomatic relief; not a targeted treatment of a specific peripheral nerve.
TENS can be a reasonable adjunct for some patients, but the stimulation is surface-level and non-targeted. Many people with chronic PDN find that TENS does not provide durable relief between sessions.
What peripheral nerve stimulation (PNS) does
Peripheral nerve stimulation places a small lead near a **specific peripheral nerve** that is driving the patient's pain. The NS100 by NeuroDynamics Global is an FDA-cleared PNS system used for chronic pain associated with painful diabetic neuropathy. It is delivered in a defined **20-day** clinical protocol.
- **Where stimulation is delivered:** directly to a targeted peripheral nerve, near the source of pain.
- **Hardware:** a minimally invasive lead placed by a trained physician in an in-office procedure; no permanent implanted generator.
- **Duration:** a continuous 20-day course of therapy; the lead is removed in a simple in-office visit on day 20.
- **Clinical role:** a non-opioid, non-pharmacologic option for patients whose chronic PDN pain has not responded adequately to first-line medications.
Because the stimulation is delivered through a lead placed near the nerve itself, PNS does not depend on the current crossing the skin and surrounding tissue to reach its target.
Side-by-side
| Attribute | TENS unit | NS100 (PNS) | | --- | --- | --- | | Prescription required | Usually no | Yes, placed by a trained physician | | Where stimulation reaches the nerve | Through the skin | At a targeted peripheral nerve | | Hardware | External pads, handheld unit | Minimally invasive lead, no permanent implant | | Treatment duration | Short, on-demand sessions | Continuous 20-day protocol | | FDA status for chronic PDN | General OTC pain device | FDA-cleared for chronic pain associated with PDN | | Typical setting | Home | In-office placement and removal |
This comparison is educational and explains how the two options differ. It is not a claim of superiority. Your clinician will decide what is appropriate for your specific situation.
When a clinician might consider PNS
First-line treatments for PDN typically include glycemic optimization, lifestyle measures, and medications such as duloxetine, pregabalin, or gabapentin. When these are not sufficient — or when side effects make them difficult to tolerate — clinicians may consider non-pharmacologic options.
A temporary, minimally invasive PNS protocol can be a reasonable next step to discuss before considering a permanently implanted system. It is non-opioid, non-pharmacologic, and leaves no permanent hardware in the body.
Frequently asked questions
**Is the NS100 just a fancy TENS unit?** No. TENS delivers current through the skin; the NS100 delivers stimulation through a lead placed near a specific peripheral nerve, in a 20-day clinical protocol supervised by a trained physician.
**Can I try TENS first and then PNS?** Many patients have used TENS before being evaluated for PNS. Your clinician can advise on sequencing based on your pain pattern and prior treatment history.
**Is NS100 a permanent implant?** No. The lead is removed in a simple in-office visit at the end of the 20-day protocol.
**Is it covered by insurance?** Coverage is payer- and plan-specific. See our [insurance coverage page](/insurance-coverage) for how benefits verification and prior authorization typically work.
Next steps
- See if a 20-day temporary PNS protocol may fit your situation: [Am I a candidate?](/am-i-a-candidate)
- Compare other options: [PNS vs. SCS](/compare/pns-vs-scs) and [Temporary vs. permanent neuromodulation](/compare/temporary-vs-permanent)
- Learn about the device: [About the NS100](/ns100)
PNS vs TENS at a glance
| Attribute | Peripheral nerve stimulation (PNS) | TENS unit |
|---|---|---|
| Mechanism | Targeted electrical stimulation of a specific peripheral nerve implicated in the pain pathway. | Broad transcutaneous current delivered across skin, modulating pain signaling non-selectively. |
| Placement | Thin percutaneous lead placed by a trained clinician near the target peripheral nerve. | Adhesive surface electrodes applied by the patient to the skin over the painful area. |
| Treatment duration | Defined 60-day percutaneous protocol (NS100); lead is removed at the end - no permanent implant. | Used on-demand by the patient for symptomatic relief; no defined therapeutic course. |
| Relief durability | Peer-reviewed PNS studies describe pain reduction that can persist after lead removal in a subset of patients. | Analgesia is generally limited to the period the device is on and shortly afterward. |
| Insurance | Covered by many commercial and Medicare Advantage plans with prior authorization for painful diabetic neuropathy. | Typically OTC / out-of-pocket for diabetic neuropathy; limited DME coverage in most plans. |
| Candidacy | Adults with chronic pain associated with painful diabetic neuropathy who have not had adequate relief from first-line therapy; determined by a clinician. | Adults seeking non-invasive, self-directed symptom relief; not a substitute for clinical management. |
Educational comparison; not a claim of superiority. Individual clinical decisions should be made with a qualified clinician.
Related reading
Frequently asked questions
- Is PNS the same as a TENS unit?
- No. Transcutaneous electrical nerve stimulation (TENS) delivers current through skin pads over a broad area and provides temporary symptom relief while active. Peripheral nerve stimulation (PNS) - for example the NS100 60-day percutaneous protocol - places a thin lead near a specific peripheral nerve so stimulation is targeted, and clinical use is guided by a trained clinician rather than self-directed.
- Does insurance cover PNS for diabetic neuropathy?
- Coverage is payer- and plan-specific and typically requires prior authorization plus documentation of chronic pain associated with painful diabetic neuropathy and prior therapy trials. Many commercial and Medicare Advantage plans have established coverage pathways for FDA-cleared peripheral nerve stimulation. TENS units are commonly available over-the-counter and are generally not covered as durable medical equipment for diabetic neuropathy in the same way. See our insurance coverage page for how benefits verification usually works.
- What happens after a 60-day PNS treatment?
- At the end of the 60-day percutaneous PNS protocol the lead is removed in-office; no permanent implant remains. Published peripheral nerve stimulation studies describe sustained pain reduction in a subset of patients after lead removal, though individual response varies and the therapy is not a cure for the underlying neuropathy. Your clinician will review results and discuss next steps, which may include continued medical management or, if indicated, other neuromodulation options.
Reviewed July 2026 by the NeuroDynamics Global Medical Affairs team (board-certified pain medicine physician, MD).
Important medical disclaimer. This content is for general informational and educational purposes only and is not medical advice, diagnosis, or treatment. It does not establish a physician–patient relationship. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or therapy.
About NS100 by NeuroDynamics Global. NS100 is an FDA-cleared Class II peripheral nerve stimulation medical device for chronic pain associated with painful diabetic neuropathy. Use of NS100 requires evaluation and prescription by a qualified healthcare provider. As with any medical device, NS100 carries potential risks; your provider will review indications, contraindications, and possible side effects with you.
Results vary. Individual results and experiences with NS100 vary from patient to patient. No specific outcome is guaranteed. Coverage and reimbursement are payer- and plan-specific.
Related Articles
Beyond Gabapentin: Drug-Free Options for Diabetic Neuropathy Relief
Gabapentin is a common first-line oral medication for painful diabetic neuropathy, but many patients don't get adequate relief or can't tolerate the side effects. Here's a plain-language look at drug-free options — including the FDA-cleared NS100 by NeuroDynamics Global.
Read educationIs Neuropathy Treatment Covered by Medicare or Insurance?
Coverage for diabetic neuropathy treatment depends on your specific plan, your diagnosis, and your treatment history. Here is how Medicare and commercial insurance generally approach coverage — and how to find out what your plan will pay.
Read educationBurning Feet from Diabetes: Causes, Warning Signs, and Treatment Options
Burning, tingling, or stabbing pain in the feet is one of the most common signs of painful diabetic neuropathy. Here is what causes it, when to act, and the treatment options worth discussing with your doctor.
Read educationCan Diabetic Neuropathy Be Reversed? What Patients Should Know
Patients newly diagnosed with diabetic neuropathy almost always ask the same question: can it be reversed? Here is an honest answer, and what you can do to slow progression and reduce pain.
ReadWant to learn more?
Talk to your healthcare provider or contact NeuroDynamics Global today.